Anaquest drug delivery agreement
Executive Summary
Under an agreement with Pharma-Logic, Anaquest will develop and market the company's microdroplet drug administration system for use with methoxyflurane. Anaquest also has rights to use the technology with analgesics and/or anesthetics and induction agents. Anaquest said the system involves packaging drugs as injectable droplets within membrane "envelopes" and could be applicable to up to one-third of the drugs listed in the Physicians' Desk Reference.